Group 1 - The CPO concept experienced significant fluctuations, with companies such as Jufei Optoelectronics and Jepu Technology reaching a 20% limit-up [1] - Other companies including Guanghe Technology, Zhongtian Technology, and Hengtong Optoelectronics also hit the limit-up [1] - Additional firms like Tianfu Communication, Yongding Co., Zhongfu Circuit, Guangxun Technology, and Taicheng Light followed with notable increases [1]

Group 1 - The core point of the article is that Benli Technology has reported its total number of shareholders as 10,254 as of February 10, 2026 [2]

Company Performance - The company reported a net profit attributable to shareholders of 11.12 million yuan for Q3 2025, representing a year-on-year increase of 24.74%, while the non-recurring net profit grew by 39.95% [1] - Despite a decline in revenue for the first three quarters of 2025, the company maintained double-digit growth in net profit, indicating improved profitability [1] - The operating cash flow net amount significantly improved, with an increase of 7907.47% in the first three quarters of 2025, reflecting enhanced collection capability and operational quality [1] Market and Technical Analysis - As of February 11, the company's stock price has risen by 9.96% since the low on January 12, with short-term moving averages (5-day, 10-day) showing a bullish arrangement [2] - The MACD indicator remains above the zero axis, and the KDJ indicator has entered the overbought zone (J value of 101.1), indicating strong technical characteristics [2] - Although there has been occasional net outflow of institutional funds, retail funds have consistently flowed in, with retail net inflow accounting for 41% on February 11, becoming a significant driving force for the stock price [2] Industry Policy and Market Conditions - At the beginning of 2026, the A-share market showed active performance, with the Shanghai Composite Index breaking through 4100 points, reaching a ten-year high, and technology stocks, along with leading companies in niche sectors, attracting capital attention [3] - The chemical raw materials sector, to which the company belongs, saw a rise of 1.15% on February 11, outperforming the broader market [3] - Institutional research indicates that new materials and pharmaceutical intermediates are key areas for brokerage firms' "spring plowing" layout, aligning with the company's main business direction [3] Company Status - The company's vice president, Sheng Mengjun, reduced his shareholding in January and resigned in February, but the scale of the reduction was small (a total of 75,000 shares, accounting for 0.07% of the share capital) [4] - The company stated that his departure would not affect normal operations [4] - The shareholding structure shows that the actual controller, Wu Zhengjie, holds 24.18% of the shares, and the top five shareholders have stable holdings, with no large-scale reduction pressure observed [4]

（文章来源：证券日报） 证券日报网讯 2月2日，本立科技在互动平台回答投资者提问时表示，截至2026年1月30日，公司股东总 人数为9968户。 ...

格隆汇2月2日丨本立科技(301065.SZ)发布公告，公司董事会于近日收到公司副总经理盛孟均提交的书 面辞任报告。盛孟均因个人原因辞去公司副总经理职务，上述职务原定任期为2024年6月7日至2027年6 月6日，其辞职后不再担任公司任何职务。盛孟均的辞任报告自送达公司董事会之日起生效。 ...

根据《公司法》《深圳证券交易所上市公司自律监管指引第2 号——创业板上市公司规范运作》等有关规定，盛孟均先生的辞任报 告自送达公司董事会之日起生效。盛孟均先生已按照公司《董事、高 级管理人员离职管理制度》的规定完成工作交接，其辞职不会对公司 正常生产经营产生影响。 截至本公告披露日，盛孟均先生直接持有公司股份225,000股 （占公司总股本的0.21%，占剔除公司回购专用证券账户股份数量后 总股本的比例为0.22%），通过台州少思投资合伙企业（有限合伙） 间接持有本公司股份262,500股（占公司总股本的0.25%，占剔除公司 回购专用证券账户股份数量后总股本的比例为0.25%）。辞职后，盛 孟均先生将继续遵守《上市公司董事和高级管理人员所持本公司股份 及其变动管理规则》《深圳证券交易所上市公司自律监管指引第18 号——股东及董事、高级管理人员减持股份》等相关法律法规有关规 定及本人在《首次公开发行股票并在创业板上市招股说明书》和《首 证券代码：301065 证券简称：本立科技 公告编号：2026-002 浙江本立科技股份有限公司 关于公司副总经理辞职的公告 本公司及董事会全体成员保证信息披露的内容真实、准确 ...

浙江本立科技股份有限公司（以下简称"公司"或"本立科技"） 于2025年12月10日披露了《关于高级管理人员减持股份预披露公告》 （公告编号：2025-046），公司副总经理盛孟均先生因个人资金需求 计划在上述公告披露之日起15个交易日后的3个月内以集中竞价交易 方式减持其直接持有的公司股份不超过75,000股，占公司总股本的 0.07%，占剔除公司回购专用证券账户股份数量后总股本的比例为 0.07%。 公司于近日收到高级管理人员盛孟均先生出具的《关于股份减持 计划实施完成的告知函》，截至本公告披露日，上述减持计划已累计 减持75,000股，占公司总股本的0.07%，上述减持计划已实施完毕。 现将本次减持计划实施情况公告如下： 证券代码：301065 证券简称：本立科技 公告编号：2026-001 浙江本立科技股份有限公司 关于高级管理人员减持计划实施完成的公告 公司副总经理盛孟均先生保证向本公司提供的信息内容真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 一、股东减持情况 1、股东减持股份情况 | 股东名称 | 减持方式 | 减持 ...

Group 1 - China Medical plans to acquire 70% equity of Zezheng Pharmaceutical for 525 million yuan to enhance its R&D capabilities in the pharmaceutical sector [1] - Hongchang Electronics has commenced production of its functional high-end copper-clad laminate electronic materials project [2] - China State Construction has secured multiple major projects totaling 32.09 billion yuan, which represents 1.5% of its audited revenue for 2024 [3] Group 2 - China Resources Double Crane has established an industrial fund with a committed investment of 83 million yuan, targeting a total fundraising goal of 500 million yuan [4] - Pinggao Electric and its subsidiaries have won state grid procurement projects worth approximately 876 million yuan, accounting for 7.06% of its 2024 revenue [5] - Dong'an Power received a government subsidy of 2.47 million yuan, with 1.47 million yuan related to assets and 1 million yuan related to income [6] Group 3 - Nantian Information has paid overdue taxes and penalties totaling 50.31 million yuan, which will impact its net profit for 2025 [7] - Erli Six has changed its investment plan to establish a wholly-owned subsidiary in Hong Kong for submarine cable business with an investment of 320 million yuan [8] - Dream Lily plans to invest 170 million yuan in an e-commerce warehouse project at its East US factory [9] Group 4 - Shen Shen Fang A's controlling shareholder has terminated the agreement to transfer 7.07% of the company's shares to Dongfang Asset, with no change in control [10] - Tianfu Culture has signed strategic cooperation framework agreements with various cultural and tourism bureaus to promote film and tourism integration [11] - Jinzi Tianzheng's chairman has resigned due to work adjustments, but will continue to fulfill his duties until a new chairman is elected [12] Group 5 - Jiangshan Oupai and its subsidiaries received government subsidies totaling 10.04 million yuan, with 7.51 million yuan related to income [13] - Ninghu Expressway plans to increase its investment in Jiangsu Danjin Expressway Co., Ltd. by 128 million yuan to support highway construction [14] - Jiangyin Bank has received approval for the qualifications of its employee director and vice president [15] Group 6 - Aoxiang Pharmaceutical has received approval for the listing application of two chemical raw materials [16] - Daye Co. has not yet commenced mass production of its robotic tendon products, with ongoing uncertainties in technology and profitability [17] - Rongsheng Environmental has proposed a cash dividend of 3.8 yuan per 10 shares, totaling approximately 97.36 million yuan [19] Group 7 - Yunyi Electric plans to invest 66 million USD in Morocco to establish a wholly-owned subsidiary and production base [20] - Derun Electronics has reached an agreement regarding the delayed payment of 100 million yuan in equity transfer funds [21] - Baihua Pharmaceutical is planning a change in control, leading to a continued suspension of its stock [22] Group 8 - CITIC Bank's executive director and president has resigned due to work adjustments [23] - Haizike's subsidiary has received acceptance for clinical trial applications for two innovative drugs [24] - Tianrun Dairy's subsidiaries received government subsidies totaling 21.53 million yuan, representing 49.32% of its net profit for 2024 [25] Group 9 - Andisou plans to issue 398 million A-shares at 7.54 yuan per share, raising a total of 3 billion yuan [26][27] - Fuda Co. has completed the transfer of its 50% stake in a joint venture, which is expected to positively impact its 2025 financial results [28] - Jianghua Micro has received environmental approval for a project to produce 37,000 tons of ultra-pure wet electronic chemicals [29] Group 10 - Nanwang Technology received a government subsidy of 10 million yuan, accounting for 0.66% of its net assets for 2024 [30] - Changgao Electric New has won state grid procurement projects totaling 161 million yuan, representing 9.14% of its 2024 revenue [31] - Huaxin Precision plans to invest up to 600 million yuan of idle funds in low-risk financial products [32] Group 11 - Fuguang Co. received a government subsidy of 1.26 million yuan for basic research projects, which is 13.27% of its net profit for 2024 [33] - Benli Technology has obtained a drug production license, which will help optimize its product structure [34] - Jintuo Co. proposed a cash dividend of 4.1 yuan per 10 shares, totaling approximately 99.48 million yuan [35] Group 12 - Kang Enbei has elected a new chairman and vice chairman during its board meeting [36] - Sanyuan Bio has completed the construction and installation of equipment for the remaining capacity of its 20,000-ton alulose project [38]

Core Viewpoint - The company has obtained its first "Drug Production License" from the Zhejiang Provincial Drug Administration, which is expected to optimize its product structure and positively impact long-term development [1] Group 1: License Acquisition - The acquisition of the "Drug Production License" marks the company's first achievement in this area [1] - The license will facilitate the optimization of the company's product structure [1] Group 2: Future Steps - The company must complete registration, on-site verification, and obtain raw material drug filing approval before commercial production and sales can commence [1] - The immediate impact of the license on the company's operating performance is expected to be minimal [1]

Core Viewpoint - The company has recently obtained a "Drug Manufacturing License" issued by the Zhejiang Provincial Drug Administration, which is valid until December 29, 2030, and will enhance the company's product structure and long-term development [1] Group 1 - The license allows the company to produce active pharmaceutical ingredients [1] - The production site is located at No. 15, East Sea Sixth Avenue, Tumen Port New District, Linhai, Zhejiang Province [1] - The acquisition of the license is expected to positively impact the company's long-term growth [1]